Curing HIV/AIDS Gets Tougher, According To New Research
Plenty of exciting developments have been made over the past year (and reported here at Instinct, accordingly). New research from scientists at Johns Hopkins and reported in the journal Cell, might dash some of the optimistic momentum as of light, however.
From a press release courtesy of Johns Hopkins:
Just when some scientists were becoming more hopeful about finding a strategy to outwit HIV’s ability to resist, evade and otherwise survive efforts to rid it from the body, another hurdle has emerged to foil their plans, new research from Johns Hopkins shows. In a cover-story report on the research to be published in the journal Cell online Oct. 24, Johns Hopkins infectious disease experts say the amount of potentially active, dormant forms of HIV hiding in infected immune T cells may actually be 60-fold greater than previously thought.
The hidden HIV, researchers say, is part of the so-called latent reservoir of functional proviruses that remains long after antiretroviral drug therapy has successfully brought viral replication to a standstill. The disappointing finding comes after a three-year series of lab experiments, which they say represents the most detailed and comprehensive analysis to date of the latent reservoir of HIV proviruses. If antiretroviral therapy is stopped or interrupted, some proviruses can reactivate, allowing HIV to make copies of itself and resume infection of other immune cells.
Senior study investigator Robert Siliciano, M.D., Ph.D., who in 1995 first showed that reservoirs of dormant HIV were present in immune cells, says that while the latest study results show most proviruses in the latent reservoir are defective, curing the disease will depend on finding a way to target all proviruses with the potential to restart the infection.
“Our study results certainly show that finding a cure for HIV disease is going to be much harder than we had thought and hoped for,” he says.
On the other hand, Johns Hopkins researchers hope the news will help focus HIV/AIDS medical approaches as well as lead to better methods of detecting if proviruses remain in a patient's cells.